In the INDI-UTI study, eligible children were between 3 months and 12 years of age, were febrile (≥38°C) at the time of or within 24 hours preceding the start of treatment, and had growth of ...

Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to ...

The global quest to prevent childhood cancer deaths has a long history. For decades, efforts have centred on driving innovation to produce more effective therapies, improve understanding in how and ...

At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...